<VariationArchive RecordType="classified" VariationID="764" VariationName="NM_015702.3(MMADHC):c.57_64del (p.Cys19_Ser20insTer)" VariationType="Deletion" Accession="VCV000000764" Version="3" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2023-12-30" DateCreated="2016-01-16" MostRecentSubmission="2023-12-30">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="15803" VariationID="764">
      <GeneList>
        <Gene Symbol="MMADHC" FullName="metabolism of cobalamin associated D" GeneID="27249" HGNC_ID="HGNC:25221" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2q23.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="149569637" stop="149587775" display_start="149569637" display_stop="149587775" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="150426146" stop="150444329" display_start="150426146" display_stop="150444329" Strand="-" />
          </Location>
          <OMIM>611935</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_015702.3(MMADHC):c.57_64del (p.Cys19_Ser20insTer)</Name>
      <CanonicalSPDI>NC_000002.12:149582216:CTAAAGAGC:C</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2q23.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="149582217" stop="149582224" display_start="149582217" display_stop="149582224" variantLength="8" positionVCF="149582216" referenceAlleleVCF="ACTAAAGAG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="150438731" stop="150438738" display_start="150438731" display_stop="150438738" variantLength="8" positionVCF="150438730" referenceAlleleVCF="ACTAAAGAG" alternateAlleleVCF="A" />
      </Location>
      <OtherNameList>
        <Name>Cys19fsTer20</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.150438732_150438739del" Assembly="GRCh37">
            <Expression>NC_000002.11:g.150438732_150438739del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.149582218_149582225del" Assembly="GRCh38">
            <Expression>NC_000002.12:g.149582218_149582225del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009189.1" sequenceAccession="NG_009189" sequenceVersion="1" change="g.10593_10600del">
            <Expression>NG_009189.1:g.10593_10600del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015702.3" sequenceAccession="NM_015702" sequenceVersion="3" change="c.57_64del" MANESelect="true">
            <Expression>NM_015702.3:c.57_64del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_056517.1" sequenceAccession="NP_056517" sequenceVersion="1" change="p.Cys19_Ser20insTer">
            <Expression>NP_056517.1:p.Cys19_Ser20insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA249854" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="611935.0004" DB="OMIM" />
        <XRef Type="rs" ID="397509361" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_015702.3(MMADHC):c.57_64del (p.Cys19_Ser20insTer) AND Vitamin B12-responsive methylmalonic acidemia, type cblDv2" Accession="RCV000000800" Version="6">
        <ClassifiedConditionList TraitSetID="194">
          <ClassifiedCondition DB="MedGen" ID="C1848554">Vitamin B12-responsive methylmalonic acidemia, type cblDv2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2008-04-03" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_015702.3(MMADHC):c.57_64del (p.Cys19_Ser20insTer) AND Methylmalonic aciduria and homocystinuria type cblD" Accession="RCV000203371" Version="3">
        <ClassifiedConditionList TraitSetID="195">
          <ClassifiedCondition DB="MedGen" ID="C1848552">Methylmalonic aciduria and homocystinuria type cblD</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-08-01" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-08-01" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2016-01-16" MostRecentSubmission="2023-12-30">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15292234</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18385497</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301409</ID>
          <ID Source="BookShelf">NBK1231</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="195" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2914" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Methylmalonic aciduria and homocystinuria type cblD</ElementValue>
                <XRef ID="MONDO:0010185" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Methylmalonic acidemia with homocystinuria cblD</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Methylmalonic aciduria with homocystinuria cblD type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">METHYLMALONIC ACIDEMIA, cblH TYPE</ElementValue>
                <XRef Type="MIM" ID="277410" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MAHCD</ElementValue>
                <XRef Type="MIM" ID="277410" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Disorders of intracellular cobalamin metabolism have a variable phenotype and age of onset that are influenced by the severity and location within the pathway of the defect. The prototype and best understood phenotype is cblC; it is also the most common of these disorders. The age of initial presentation of cblC spans a wide range: In utero with fetal presentation of nonimmune hydrops, cardiomyopathy, and intrauterine growth restriction. Newborns, who can have microcephaly, poor feeding, and encephalopathy. Infants, who can have poor feeding and slow growth, neurologic abnormality, and, rarely, hemolytic uremic syndrome (HUS). Toddlers, who can have poor growth, progressive microcephaly, cytopenias (including megaloblastic anemia), global developmental delay, encephalopathy, and neurologic signs such as hypotonia and seizures. Adolescents and adults, who can have neuropsychiatric symptoms, progressive cognitive decline, thromboembolic complications, and/or subacute combined degeneration of the spinal cord.</Attribute>
                <XRef ID="NBK1328" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3582" />
                <XRef ID="3582" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301409</ID>
                <ID Source="BookShelf">NBK1231</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301503</ID>
                <ID Source="BookShelf">NBK1328</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Elevated%20C3%20Acylcarnitine%20PA%20and%20MA.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated C3 Acylcarnitine, Propionic Acidemia (PA) and Methylmalonic Acidemia (MMA), 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C3-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Propionic and Methylmalonic Acidemia: C3 Elevated, 2022</CitationText>
              </Citation>
              <XRef ID="622" DB="Orphanet" />
              <XRef ID="79283" DB="Orphanet" />
              <XRef ID="C1848552" DB="MedGen" />
              <XRef ID="MONDO:0010185" DB="MONDO" />
              <XRef Type="MIM" ID="277410" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="194" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="9331" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Vitamin B12-responsive methylmalonic acidemia, type cblDv2</ElementValue>
                <XRef ID="MONDO:0017685" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Methylmalonic aciduria, cblD type, variant 2</ElementValue>
                <XRef ID="METHYLMALONIC+ACIDURIA%2C+cblD+TYPE%2C+VARIANT+2/8867" DB="Genetic Alliance" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17391" />
                <XRef ID="17391" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Elevated%20C3%20Acylcarnitine%20PA%20and%20MA.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated C3 Acylcarnitine, Propionic Acidemia (PA) and Methylmalonic Acidemia (MMA), 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C3-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Propionic and Methylmalonic Acidemia: C3 Elevated, 2022</CitationText>
              </Citation>
              <XRef ID="308442" DB="Orphanet" />
              <XRef ID="C1848554" DB="MedGen" />
              <XRef ID="MONDO:0017685" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="20950" SubmissionDate="2018-01-12" DateLastUpdated="2018-01-15" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="611935.0004_METHYLMALONIC ACIDURIA, cblD TYPE, VARIANT 2" title="MMADHC, 8-BP DEL, NT57_METHYLMALONIC ACIDURIA, cblD TYPE, VARIANT 2" />
        <ClinVarAccession Accession="SCV000020950" DateUpdated="2018-01-15" DateCreated="2013-04-04" Type="SCV" Version="5" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2008-04-03">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In an Indian boy with methylmalonic aciduria complementation group cblD (see 277410), Coelho et al. (2008) identified a homozygous 8-bp deletion (57delCTCTTTAG) in the MMADHC gene, resulting in a frameshift and premature termination at codon 20. The patient was previously reported by Suormala et al. (2004). He was born prematurely at 32 weeks' gestation and showed severe respiratory distress syndrome, necrotizing enterocolitis, and seizures.</Attribute>
              <Citation>
                <ID Source="PubMed">18385497</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">15292234</ID>
              </Citation>
              <XRef DB="OMIM" ID="277410" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MMADHC" />
          </GeneList>
          <Name>MMADHC, 8-BP DEL, NT57</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">8-BP DEL, NT57</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="611935.0004" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">METHYLMALONIC ACIDURIA, cblD TYPE, VARIANT 2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="483241" SubmissionDate="2016-01-07" DateLastUpdated="2022-10-01" DateCreated="2016-01-16">
        <ClinVarSubmissionID localKey="NM_015702.2:c.57_64delCTCTTTAG|OMIM:277410" />
        <ClinVarAccession Accession="SCV000258516" DateUpdated="2022-10-01" DateCreated="2016-01-16" Type="SCV" Version="2" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Citation>
            <ID Source="BookShelf">NBK1231</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MMADHC" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NP_056517.1:p.Ser20Ter</Name>
            <Name>Cys19fsTer20</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015702.2:c.57_64delCTCTTTAG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1848552" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11808016</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7842759" SubmissionDate="2023-12-07" DateLastUpdated="2023-12-30" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_015702.3:c.57_64del|OMIM:277410" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004193232" DateUpdated="2023-12-30" DateCreated="2023-12-30" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-08-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015702.3:c.57_64del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="277410" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="20950" TraitType="Disease" MappingType="Name" MappingValue="METHYLMALONIC ACIDURIA, cblD TYPE, VARIANT 2" MappingRef="Preferred">
        <MedGen CUI="C1848554" Name="Vitamin B12-responsive methylmalonic acidemia, type cblDv2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7842759" TraitType="Disease" MappingType="XRef" MappingValue="277410" MappingRef="OMIM">
        <MedGen CUI="C1848552" Name="Methylmalonic aciduria and homocystinuria type cblD" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="483241" TraitType="Disease" MappingType="XRef" MappingValue="C1848552" MappingRef="MedGen">
        <MedGen CUI="C1848552" Name="Methylmalonic aciduria and homocystinuria type cblD" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>